Proposals on wastewater treatment will jeopardise patient access to medicines without helping green transition

26 October 2022

Rapid policy action needed to protect patient access to essential medicines as inflation bites

12 October 2022

EU pharmaceutical legislation reform critical to sustain biosimilar medicines competition for the future

6 October 2022

Updated Guide to empower nurses managing patients on biological therapies

3 October 2022

Open Medicines for Europe letter ahead of the Energy Council – 27 September 2022

27 September 2022

EMA/HMA share definitive EU-wide position on biosimilar medicines interchangeability

19 September 2022

Medicines for Europe is part of the REMEDi4ALL consortium! An EU-funded research initiative aiming at driving forward the repurposing of medicines in Europe

2 September 2022

REMEDi4ALL launched yesterday with the aim of making a major […]

Medicines for Europe warns strongly against energy rationing for medicines production

20 July 2022

The Supplementary Protection Certificate (SPC) manufacturing waiver becomes operational!

1 July 2022

The off-patent medicines industry is a vital part of the solution for healthcare resilience

30 June 2022